A depot-forming glucagon-like peptide-1 fusion protein reduces blood glucose for five days with a single injection.
about
A thermo-responsive protein treatment for dry eyes.Protein polymer nanoparticles engineered as chaperones protect against apoptosis in human retinal pigment epithelial cellsElastin based cell-laden injectable hydrogels with tunable gelation, mechanical and biodegradation properties.Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.Expression and Characterization of a Potent Long-Acting GLP-1 Receptor Agonist, GLP-1-IgG2σ-Fc.Protein-polymer conjugation-moving beyond PEGylation.Creating cellular patterns using genetically engineered, gold- and cell-binding polypeptides.The development and characterization of SDF1α-elastin-like-peptide nanoparticles for wound healing.Stromal Cell-Derived Growth Factor-1 Alpha-Elastin Like Peptide Fusion Protein Promotes Cell Migration and Revascularization of Experimental Wounds in Diabetic Mice.One-pot Synthesis of Elastin-like Polypeptide Hydrogels with Grafted VEGF-Mimetic Peptides.Controlled release from recombinant polymersApplications of elastin-like polypeptides in drug delivery.Elastin-like polypeptides: Therapeutic applications for an emerging class of nanomedicines.Controlled release of biologics for the treatment of type 2 diabetes.Half-life extended biotherapeutics.Elastin-like polypeptides: A strategic fusion partner for biologics.Half-Life Extension of Biopharmaceuticals using Chemical Methods: Alternatives to PEGylation.Protein based therapeutic delivery agents: Contemporary developments and challenges.Sustained intra-articular delivery of IL-1RA from a thermally-responsive elastin-like polypeptide as a therapy for post-traumatic arthritisSelf-assembled hybrid elastin-like polypeptide/silica nanoparticles enable triggered drug release.Berunda Polypeptides: Multi-Headed Fusion Proteins Promote Subcutaneous Administration of Rapamycin to Breast Cancer In Vivo.Recombinant Synthesis of Hybrid Lipid-Peptide Polymer Fusions that Self-Assemble and Encapsulate Hydrophobic Drugs.Improving long-term subcutaneous drug delivery by regulating material-bioenvironment interaction.Fusion of fibroblast growth factor 21 to a thermally responsive biopolymer forms an injectable depot with sustained anti-diabetic action.Molecular Size Modulates Pharmacokinetics, Biodistribution, and Renal Deposition of the Drug Delivery Biopolymer Elastin-like Polypeptide.
P2860
Q28115093-7060E0CF-DFAB-4CDC-AAAB-AB3F3FB00FD1Q34465338-C61E0608-0FF1-40AA-963D-46BF31C376A3Q35569745-31A03168-ECE8-472F-8BF9-7D9A10B41D76Q35684362-BD5B0DF2-97A4-45F8-B535-E765FD529057Q36032335-3EEBAA37-B987-4145-9DE9-7414CAE2D129Q36220152-D17A044D-EB70-48F9-AE67-2D0D76DFEDF6Q36944879-96B937C0-639B-49F2-BC92-D2B4C732C98DQ36973357-7E03D75F-FC97-4E10-ABF7-F8AC6044A96FQ37571968-D1D0FBF9-F545-4DB7-B871-06AF71AB580DQ37692002-D3DEC652-2C19-436A-8AC8-AC22EB2115E0Q38222535-3F72EB2B-3D0D-4C02-8992-AAF8C26E85D0Q38224685-5B281945-86B6-4C40-95AC-680DADD329B7Q38636559-3C18B6F4-CA2B-4A02-A4AE-E65B703E24A6Q38665753-A9C5EC14-CD39-442D-AD78-F364E04C6652Q38770067-895E810C-B53A-400B-9C05-DCABBCBC8551Q38816648-2542BB82-4D11-4C34-B2C1-AFEEAA52A77CQ38989309-61F7C022-32D2-40D1-85BA-1F7AAE38181BQ39273739-78939C65-401A-4186-9AB0-42E99D2FEC10Q41504272-0FBE9E12-D432-468F-BDA0-377D168546EFQ46275192-1114DCC7-68BE-4305-9A97-026617DAEF03Q47171615-78F9F3B1-BE26-4521-8AD8-552FA0D67F18Q47706872-6B21C643-77B0-471D-B080-223E646CABABQ49391770-E5219BB6-FBF4-48F4-B296-2E00F1EBF00EQ52649955-4AE9047A-7248-4563-80FF-58C63F5EC484Q55039164-E8940191-F643-4A21-AA92-FBD2BE928D14
P2860
A depot-forming glucagon-like peptide-1 fusion protein reduces blood glucose for five days with a single injection.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A depot-forming glucagon-like ...... days with a single injection.
@en
A depot-forming glucagon-like ...... days with a single injection.
@nl
type
label
A depot-forming glucagon-like ...... days with a single injection.
@en
A depot-forming glucagon-like ...... days with a single injection.
@nl
prefLabel
A depot-forming glucagon-like ...... days with a single injection.
@en
A depot-forming glucagon-like ...... days with a single injection.
@nl
P2093
P2860
P1476
A depot-forming glucagon-like ...... days with a single injection.
@en
P2093
P2860
P304
P356
10.1016/J.JCONREL.2013.07.021
P407
P577
2013-08-06T00:00:00Z